Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial

Jeonggeun Moon1, Se-Joong Rim, In Jeong Cho

  • 1Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

Insights

Regression of left ventricular hypertrophy (LVH) in hypertensive patients with nonvalvular atrial fibrillation (NV-AF) is linked to improved outcomes. This study found LVH is independently associated with left atrial enlargement, suggesting LVH regression may improve diastolic function and reduce stroke risk.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Atrial Fibrillation Studies

Background:

  • Regression of left ventricular hypertrophy (LVH) is associated with reduced stroke incidence in hypertensive patients with nonvalvular atrial fibrillation (NV-AF).
  • The precise mechanisms linking LVH regression to improved outcomes in NV-AF remain incompletely understood.
  • Recent findings suggest diastolic dysfunction (DD) correlates with ischemic stroke risk in NV-AF patients.

Purpose of the Study:

  • To investigate the hypothesis that hypertension (HTN) and resultant LVH are associated with the severity of diastolic dysfunction (DD) in NV-AF.
  • To explore the relationship between left ventricular mass index (LVMI) and left atrial (LA) volume in NV-AF patients.

Main Methods:

  • A cohort of 294 patients with NV-AF and preserved LV systolic function were analyzed.
  • Clinical and echocardiographic data were compared between patients with enlarged LA volume and those with normal LA.
  • Multivariate analysis was employed to identify independent predictors of increased LA volume.

Main Results:

  • Patients with enlarged LA volume were older, had a higher prevalence of males, longer NV-AF duration, and elevated brain natriuretic peptide levels.
  • Significant differences were observed in right ventricular systolic pressure, mitral inflow velocity (E), LV mass index (LVMI), and E/E' ratio between groups.
  • Multivariate analysis revealed LVMI was independently correlated with increased LA volume (OR: 1.037 [95% CI: 1.011-1.063], P < 0.05), while HTN was not.

Conclusions:

  • Left atrial enlargement, reflecting DD severity and chronicity, is independently associated with LVH in NV-AF patients.
  • LVMI is a significant independent predictor of LA enlargement in this population.
  • Regression of LVH through antihypertensive treatment may improve diastolic function and lead to favorable clinical outcomes in hypertensive NV-AF patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...